RR

Ragini Rani

Active Director Director DIN 10076137
DIN 10076137 First appointment Mar 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Ragini Rani

Data last updated:

Ragini Rani is a Director at Malay Pharma Private Limited (since 2023). The company operates in Paper. Malay Pharma Private Limited reported revenue of ₹2.25 Cr (FY 2025).

DIN 10076137
Primary Designation Director
Industry Paper
First Appointment 16 Mar 2023
Oldest Company Age 3 yrs
Largest company Malay Pharma Private Limited · ₹2.25 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Malay Pharma Private Limited U21002BR2023PTC062024
Director16 Mar 20232023₹2.25 Cr (FY 2025)Active

Board colleagues of Ragini Rani

NameDINCompanyDesignation
Arun Kumar Singh10076138Malay Pharma Private LimitedDirector
Ritwik Singh10076139Malay Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Malay Pharma Private Limited
Premium access

Shareholding and investment profile for Ragini Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ragini Rani

Ragini Rani currently holds 1 directorship: Malay Pharma Private Limited (Director, since 16 Mar 2023, revenue ₹2.25 Cr (FY 2025)).

Ragini Rani was first appointed on 16 Mar 2023 as Director at Malay Pharma Private Limited.

The current boards of Ragini Rani's companies include Arun Kumar Singh (Malay Pharma Private Limited), Ritwik Singh (Malay Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available